| Patient | Pablo Neruda |
|---|---|
| Date of birth | 1904-07-12 |
| Identifiers | MRN HR-ML051-SYN-TD; SSN (made up) 000-51-2976 |
| Document date | 1971-06-01 |
| Author | Marisol Fairweather-Diaz, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Man of 66 with four months of urinary symptoms and six weeks of right hip and low back pain, a hard nodular prostate, PSA 46.8 ng/mL and a raised alkaline phosphatase: suspected metastatic prostate cancer. Please confirm the diagnosis and extent and advise on treatment, including bone health and genetic testing. [S]
Urgency: Urgent, within two weeks. [S]
Questions for the consultant:
Poet and diplomat, posted abroad; Spanish is his first language and a professional interpreter is used. Four months of frequency, weak stream and nocturia three times (IPSS 17); six weeks of aching right buttock and hip pain and low back pain, worse at night, pain 6 of 10. No leg weakness, numbness, or change in bladder or bowel control. Digital rectal examination: hard, nodular right lobe with loss of the right lateral border. Hypertension for five years on amlodipine 5 mg; blood pressure 146/88 mm Hg today. Never smoker. Laboratory tests today: PSA 46.8 ng/mL, testosterone 468 ng/dL, hemoglobin 13.6 g/dL, creatinine 0.96 mg/dL, calcium 9.6 mg/dL, alkaline phosphatase 168 U/L, LDH 208 U/L, hemoglobin A1c 5.9 percent, LDL 140 mg/dL, 25-hydroxyvitamin D 22 ng/mL. PHQ-9 score 6. MRI of the prostate, a targeted biopsy at the urology practice, CT of the chest, abdomen and pelvis, a bone scan and PSMA PET/CT are being arranged before your visit. Acetaminophen started for pain [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
9 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1966-04-06 to 1971-07-13 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) up to three times daily as needed for bone pain | Two tablets up to three times daily as needed | Oral route | 1971-06-01 to 1971-09-14 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Urinary frequency, weak stream and nocturia for four months, with right hip and low back pain for six weeks, a hard nodular prostate and a raised PSA; suspected prostate cancer, to be confirmed | active | confirmed | R97.20 | S — Synthetic presenting problem, resolved at the second visit when biopsy and staging established metastatic prostate cancer. |
| Essential hypertension for five years, on amlodipine | active | confirmed | I10 | S — Synthetic comorbidity, relevant to cardiovascular risk on androgen deprivation; not a claim about his real blood pressure. |
| Prediabetes (hemoglobin A1c 5.9%) | active | confirmed | R73.03 | S — Synthetic metabolic finding at intake, relevant to androgen deprivation. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Died shortly after his birth; cause not recorded in the cited source | D (CLM-0001) |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1971-06-01 | Body height | 178 | cm | S |
| 1971-06-01 | Body weight | 92.4 | kg | S |
| 1971-06-01 | Body mass index (BMI) [Ratio] | 29.2 | kg/m2 | S |
| 1971-06-01 | Systolic blood pressure | 146 | mm[Hg] | S |
| 1971-06-01 | Diastolic blood pressure | 88 | mm[Hg] | S |
| 1971-06-01 | Heart rate | 76 | /min | S |
| 1971-06-01 | Respiratory rate | 14 | /min | S |
| 1971-06-01 | Body temperature | 36.7 | Cel | S |
| 1971-06-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1971-06-01 | Prostate specific Ag [Mass/volume] in Serum or Plasma | 46.8 | ng/mL | <=4 ng/mL | High | S |
| 1971-06-01 | Testosterone [Mass/volume] in Serum or Plasma | 468 | ng/dL | 264 to 916 ng/dL in adult men; below 50 ng/dL is the castrate target on androgen deprivation | Normal | S |
| 1971-06-01 | Hemoglobin [Mass/volume] in Blood | 13.6 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1971-06-01 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1971-06-01 | Platelets [#/volume] in Blood by Automated count | 248 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1971-06-01 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1971-06-01 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1971-06-01 | Glucose [Mass/volume] in Serum or Plasma | 104 | mg/dL | 70-99 mg/dL | High | S |
| 1971-06-01 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1971-06-01 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1966)/1.73 sq M | 87 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1971-06-01 | Calcium [Mass/volume] in Serum or Plasma | 9.6 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1971-06-01 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-55 U/L | Normal | S |
| 1971-06-01 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 8-48 U/L | Normal | S |
| 1971-06-01 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 168 | U/L | 40-129 U/L | High | S |
| 1971-06-01 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 1971-06-01 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 208 | U/L | 135-225 U/L | Normal | S |
| 1971-06-01 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | % | <=5.6% | High | S |
| 1971-06-01 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 1971-06-01 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 46 | mg/dL | >=40 mg/dL | Normal | S |
| 1971-06-01 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 140 | mg/dL | <=129 mg/dL | High | S |
| 1971-06-01 | Triglyceride [Mass/volume] in Serum or Plasma | 140 | mg/dL | <=149 mg/dL | Normal | S |
| 1971-06-01 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 22 | ng/mL | 30-100 ng/mL | Low | S |
| 1971-06-01 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1971-06-01 | International Prostate Symptom Score [IPSS] | 17 | {score} | S | ||
| 1971-06-01 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 6 | {score} | S |